DUBLIN, Calif., Nov 3 SuperGen, Inc. (Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that James S. Manuso, Ph.D., President and Chief Executive Officer, is scheduled to present at the Rodman & Renshaw 10th Annual Healthcare Conference on Monday, November 10, 2008, at the New York Palace Hotel.
SuperGen's presentation at the Rodman & Renshaw 10th Annual Healthcare Conference is scheduled to begin at 11:35 a.m. EDT (8:35 a.m. PDT). A live webcast of the presentation will be available on the investor relations section of the Company's Web site at www.supergen.com. The webcast will be archived for 90 days.
Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical company dedicated to the discovery and development of novel cancer therapies. SuperGen is developing a number of therapeutic anticancer products focused on kinase and cell signaling inhibitors and DNA methyltransferase inhibitors. For more information about SuperGen, please visit http://www.supergen.com.
Contacts: SuperGen, Inc. Timothy L. Enns SVP, Corporate Communications & Business Development Tel: (925) 560-0100 Email: firstname.lastname@example.org Mary M. Vegh Manager, Investor Relations Tel: (925) 560-2845 E-mail: email@example.com Dorland Global Public Relations Michael Beckerich (Media) Tel: (212) 677-7632 firstname.lastname@example.org
SOURCE SuperGen, Inc.